| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $474.7M | -11.4% |
| Cost of Revenue | $347.5M | -8.0% |
| Gross Profit | $127.2M | -19.6% |
| R&D Expense | $9.6M | +31.7% |
| SG&A Expense | $54.9M | -16.1% |
| Operating Income | $23.9M | -46.7% |
| Pre-tax Income | $19.2M | -61.0% |
| Income Tax | $5.8M | -40.5% |
| Net Income | $13.4M |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.2M | -58.5% |
| Accounts Receivable | $55.9M | -5.4% |
| Current Assets | $277.3M | -3.7% |
| Total Assets | $559.6M | -3.2% |
| Current Liabilities | $66.6M | -31.1% |
| Total Liabilities | $187.2M | +4.1% |
| Stockholders' Equity | $372.5M | -6.5% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -106.8% |
| Capital Expenditures | $21.6M | -76.2% |
| Investing Cash Flow | -$19.2M | +76.5% |
| Financing Cash Flow | -$9.2M | +48.7% |
| Free Cash Flow | -$28.8M | -280.4% |
| -66.1% |
| EPS (Basic) | $0.30 | -65.1% |
| EPS (Diluted) | $0.30 | -65.1% |